Evofem receives OTCQB delisting notice for bid price below $0.01

Evofem Biosciences, Inc.

Received OTC Markets notice on Aug 28, 2024 for bid price below $0.01 for 30 consecutive trading days.
Has 90-day compliance period until Nov 26, 2024 to regain minimum bid price requirement.
Compliance can be met if bid price is at least $0.01 for 10 consecutive trading days.
Failure to comply by Nov 26 will result in removal of common stock from OTCQB.
Company will monitor and consider available options; no assurance of regaining compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.